
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
Click the title above for a link to open the Pharmaceutical Commerce August 2023 issue in an interactive PDF format.
about 3 years ago
Telling the 'Whole' Storyabout 3 years ago
Collaboration at the Forefrontabout 3 years ago
The Voyage to Beantownabout 3 years ago
Are CEOs Getting Access Right?about 3 years ago
AFP Caution Flag for Patientsabout 3 years ago
Breaking the Pharma Industry’s Bundled Pricing Arrangementsabout 3 years ago
Doubling Down on Drug Adherenceabout 3 years ago
Wholesalers Step Up Their Partneringabout 3 years ago
Are ADMs a Viable Option for Pharma?about 3 years ago
Exploring Uses of RFID Technology





